http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3249407-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d0482ebcc95acca638f550eace5fb89 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56994 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a843645b4a3a8b95f15c293d033db242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7257687bccc741427324d394e5648f85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_816240b4c4d491765d1decc76b2a6669 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a25773063d50e1a2fb68baa267d28dc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04220f58ce2af0ad803b805537cb9ff2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd70cf85363b6848dfb4c12f710c2ddf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ff3b62e6a5eeae41f6671a17a53260b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b2365ef457f893096051ba3805a15d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e98563675309f45ed09bb2ac34a823 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db42e81593497eb8c1f005899b77ea90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e072151bcb171f97e93780698daba64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cba01d28de778593ed1685e6af76a61 |
| publicationDate | 2017-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3249407-A1 |
| titleOfInvention | Method for determining herpes b virus and assay system therefore |
| abstract | In a first aspect, the present invention relates to a method for determining the presence of herpes B virus, or for determining the status of herpes B virus infection in primates based on detection of antibodies against herpes B virus. In particular, the present invention relates to a method wherein at least two different peptides of short amino acid sequences with 4 to 40 amino acid residues present in the herpes B virus glycoproteins B, C, D, G, H and/or L are detected representing target regions of antibodies being specific against herpes B virus allowing determination of the presence of herpes B virus or determining the status of the herpes B virus infection in primates based on the presence and/or amount of the antibodies accordingly. In a further aspect, the present invention relates to an assay system for determining the presence of herpes B virus comprising at least said two different peptides derived from the herpes B virus glycoproteins B, C, D, G, H and/or L representing target regions of antibodies being specific against herpes B virus as well as means for determining the presence of said antibodies binding specifically to said peptides. Finally, the present invention relates to the use of at least two peptides comprising short amino acid sequences with 4 to 40 amino acids containing at least two different epitopes derived from herpes B glycoproteins B, C, D, G, H and/or L for determining the presence of herpes B virus or for determining the status of herpes B virus infection in primates. |
| priorityDate | 2016-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 221.